Psilocybin-Assisted Psychotherapy for Veterans With PTSD
ARQ National Psychotrauma Centre
View at source ↗Clinical trial
Source: ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters. Not a U.S. Government endorsement.
Brief summary
This study will evaluate the feasibility, safety and preliminary efficacy of psilocybin-assisted psychotherapy in military veterans with treatment-refractory posttraumatic stress disorder (PTSD).
Source: ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters. Not a U.S. Government endorsement.
Trial details
- acronym
- PsiVet
- status
- NOT_YET_RECRUITING
- phase
- PHASE2
- study type
- INTERVENTIONAL
- enrollment
- 12
- sponsor
- ARQ National Psychotrauma Centre
- conditions
- Posttraumatic Stress Disorder (PTSD)
- interventions
- DRUG: Psilocybin-assisted Psychotherapy
- start date
- 2026-12-01
- start date type
- ESTIMATED
- primary completion date
- 2028-12-01
- has results
- false
- data source
- ClinicalTrials.gov
- data processed
- 2026-10-29T09:00:05
- modifications
- selected fields only; whitespace normalized; brief summary truncated to 2,000 characters
Record
- Archive ID
- nct:NCT07792538
- Published
- Aug 28, 2026
- Venue
- ClinicalTrials.gov
- ClinicalTrials.gov
- NCT07792538
- Categories
- Posttraumatic Stress Disorder (PTSD)
- License
- ClinicalTrials.gov terms (attribution, processing date, modifications noted)
- Provenance
- clinicaltrials